• 60 Hits
  • Search Condition : Filter (MeSH = Pancreatic Neoplasms / pathology*)
Species Resource Title
Human and Animal Cells PK-8(RCB2700) , PK-59(RCB1901) , MIA Paca2(RCB2094) Metabolic shift to serine biosynthesis through 3-PG accumulation and PHGDH induction promotes tumor growth in pancreatic cancer.
Human and Animal Cells PANC-1(RCB2095) Expression of KL-6/MUC1 in pancreatic cancer tissues and its potential involvement in tumor metastasis.
Human and Animal Cells HaP-T1(RCB0441) Efficacy of oncolytic reovirus against liver metastasis from pancreatic cancer in immunocompetent models.
Human and Animal Cells MRC-5(RCB0211) Radiation to stromal fibroblasts increases invasiveness of pancreatic cancer cells through tumor-stromal interactions.
Human and Animal Cells PANC-1(RCB2095) Autotaxin in ascites promotes peritoneal dissemination in pancreatic cancer.
Human and Animal Cells MIA Paca2(RCB2094) , PANC-1(RCB2095) α1,6-Fucosyltransferase contributes to cell migration and proliferation as well as to cancer stemness features in pancreatic carcinoma.
Human and Animal Cells PANC-1(RCB2095) Impact of Oncogenic Targets Controlled by Tumor-Suppressive miR-30a-5p in Pancreatic Ductal Adenocarcinoma.
Human and Animal Cells PK-59(RCB1901) , PANC-1(RCB2095) , PK-1(RCB1972) , PK-45H(RCB1973) , KP4-1(RCB1006) Roles of voltage‑gated potassium channels in the maintenance of pancreatic cancer stem cells.
Human and Animal Cells PANC-1(RCB2095) GLI1 facilitates the migration and invasion of pancreatic cancer cells through MUC5AC-mediated attenuation of E-cadherin.
Human and Animal Cells PK-45H(RCB1973) , PANC-1(RCB2095) , MIA Paca2(RCB2094) , KP4-1(RCB1006) Depleted tumor suppressor miR-107 in plasma relates to tumor progression and is a novel therapeutic target in pancreatic cancer.
Human and Animal Cells MIA Paca2(RCB2094) Ribonucleotide reductase is an effective target to overcome gemcitabine resistance in gemcitabine-resistant pancreatic cancer cells with dual resistant factors.
Human and Animal Cells PANC-1(RCB2095) ZFP36L2 promotes cancer cell aggressiveness and is regulated by antitumor microRNA-375 in pancreatic ductal adenocarcinoma.
Human and Animal Cells PK-1(RCB1972) , PK-8(RCB2700) , PK-45P(RCB2141) , PK-59(RCB1901) , KP4(RCB1005) , NOR-P1(RCB2139) , T3M-4(RCB1021) Atypical KRASG12R Mutant Is Impaired in PI3K Signaling and Macropinocytosis in Pancreatic Cancer.
Human and Animal Cells HuH-7 MicroRNA-1291 targets the FOXA2-AGR2 pathway to suppress pancreatic cancer cell proliferation and tumorigenesis.
DNA material 8x3'Gli-BS-delta51-LucII (RDB08061) , pcDNA3.1-His-hGLI1 (RDB08063) Upregulation of amplified in breast cancer 1 contributes to pancreatic ductal adenocarcinoma progression and vulnerability to blockage of hedgehog activation.
Human and Animal Cells PANC-1(RCB2095) Chemical constituents of Thai Piper ribesoides and their antiausterity activities against the PANC-1 human pancreatic cancer cell line.
Human and Animal Cells PANC-1(RCB2095) Necroptosis in pancreatic cancer promotes cancer cell migration and invasion by release of CXCL5.
Human and Animal Cells PK-1(RCB1972) , PK-45H(RCB1973) , PK-8(RCB2700) Cancer-associated adipocytes promote pancreatic cancer progression through SAA1 expression.
Human and Animal Cells MIA Paca2(RCB2094) , PANC-1(RCB2095) The Cell Line-Dependent Diversity in Initial Morphological Dynamics of Pancreatic Cancer Cell Peritoneal Metastasis Visualized by an Artificial Human Peritoneal Model.
Human and Animal Cells PANC-1(RCB2095) Hypoxic stellate cells of pancreatic cancer stroma regulate extracellular matrix fiber organization and cancer cell motility.